ABRF Corporate Partner Presentation – QIAGEN: Single-cell Data at Scale
ABRF Corporate Partner Presentation – QIAGEN: Single-cell Data at Scale
October 29, 2026
12:00 – 1:00 pm ET
Register Here
The ABRF Corporate Relations Committee invites you to join us for an upcoming webinar presented by ABRF Signature Partner Qiagen.
Single-cell Data at Scale:
From single-cell transcriptomics data to confident biological interpretation – in minutes
The growing scale of single-cell transcriptomics enables increasingly granular exploration of cell states, but traditional methods for identifying biological differences between single-cell clusters assume rigid and distinct cell states.
In this session, you’ll learn how to predict activity of upstream regulators, canonical pathways, and biological functions directly on single-cell data, at the cell level. Cell-level activity prediction can resolve subgroups that computational clustering alone may miss, and it supports rapid hypothesis generation that you can interrogate with statistical analysis in QIAGEN Ingenuity Pathway Analysis.
This program is the fifth installment in the Educational Webinar Series 2026, moving from experimental design and data generation to interpretation.
Join us for this session to learn:
• How to predict activity of upstream regulators, canonical pathways, and biological functions directly at the single-cell level
• How cell-level activity prediction can uncover subgroups that computational clustering alone may miss
• How to use cell-level insights to generate hypotheses for follow-up analysis
• How to validate those hypotheses with statistical analysis in QIAGEN Ingenuity Pathway Analysis
Presenter:
Joseph Pearson, Ph.D.
Director, Global Product Management OmicSoft
QIAGEN Digital Insights
Presenter Biography
Dr. Pearson is the Global Product Manager for QIAGEN OmicSoft products, which enable scientists to harness the breadth of deeply-curated ‘omics data to accelerate biomarker and target discovery research. Prior to joining QIAGEN, he earned his Ph.D at the University of California, San Diego, where he used computational and experimental approaches to decipher cis¬-regulatory codes controlling epidermal wound responses. During his post-doctoral research at University of North Carolina, Chapel Hill, Dr. Pearson continued to explore the diversity of cis¬-regulatory mechanisms, using genomics, transgenics, microscopy, and bioinformatics to isolate and dissect enhancers responsible for early nervous system gene expression.
We look forward to seeing you for this timely presentation. Contact us if you have questions.
Thank you.
ABRF Corporate Relations Committee